Clinphone completes MHRA inspection

8 June 2008

ClinPhone, which says it is the world's largest clinical technology organization, has received the Good Clinical Practice Inspection Statement to complete the latest inspection by the GCP Inspectorate of the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

As with any organization involved in the clinical trials process, ClinPhone says it has implemented rigorous procedures to ensure compliance with GCP. These are assessed by clients, who conduct in excess of 40 audits per year at ClinPhone, as well as by Regulatory Authorities.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight